Table of contents

7th International Symposium on Advanced Ovarian Cancer

• Editorial (1 November, 2009)

  Andrés Poveda, Jan B. Vermorken
• Proteomic Profiling in Ovarian Cancer (1 November, 2009)

  Geoffrey Kim, Lucas Minig, Elise C. Kohn
• Laparoscopy Staging of Early Ovarian Cancer: Our Experience and Review of the Literature (1 November, 2009)

  Fabio Ghezzi, Antonella Cromi, Gabriele Siesto, Maurizio Serati, Eleonora Zaffaroni, Pierfrancesco Bolis
• Prognostic Factors for Complete Debulking in First- and Second-Line Ovarian Cancer (1 November, 2009)

  Philipp Harter, Felix Hilpert, Sven Mahner, Stefan Kommoss, Florian Heitz, Jacobus Pfisterer, Andreas du Bois
• Lymph Node-Positive Stage IIIC Ovarian Cancer: A Separate Entity? (1 November, 2009)

  Jonathan S. Berek
• Ovarian Cancer: Markers of Response (1 November, 2009)

  Young-Jeong Na, John Farley, Audrey Zeh, Marcela del Carmen, Richard Penson, Michael J. Birrer
• Pharmacogenomics of Taxane/Platinum Therapy in Ovarian Cancer (1 November, 2009)

  Sharon Marsh
• Consolidation Therapy in Ovarian Cancer: A Clinical Update (1 November, 2009)

  Paul Sabbatini
• Optimal Management of Recurrent Ovarian Cancer (1 November, 2009)

  Maurie Markman
• Symptom Control in Patients With Recurrent Ovarian Cancer: Measuring the Benefit of Palliative Chemotherapy in Women With Platinum Refractory/Resistant Ovarian Cancer (1 November, 2009)

  Michael Friedlander, Phyllis Butow, Martin Stockler, Corona Gainford, Julie Martyn, Amit Oza, Heidi S. Donovan, Brigitte Miller, Madeline King
• Other New Targets (1 November, 2009)

  Helen J. Mackay, Amit M. Oza
• Trials With Impact on Clinical Management: First Line (1 November, 2009)

  Michael A. Bookman
• Changing the Paradigm in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: From Platinum Doublets to Nonplatinum Doublets and Adding Antiangiogenesis Compounds (1 November, 2009)

  Bradley J. Monk, Robert L. Coleman